Amyotrophic Lateral Sclerosis (ALS), often referred to as Lou Gehrig's disease, is a neurodegenerative disease characterized by progressive and irreversible degeneration of upper motor neurons (UMN) and lower motor neurons (LMN). UMN death leads to hyper-excitability and spasticity, while LMN degeneration causes weakness, fasciculation and muscular atrophy, followed by progressive paralysis.
Creative Bioarray offers an extensive portfolio of in vitro cellular models and drug screening platform for Amyotrophic Lateral Sclerosis (ALS) studies.
